TRETHIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Oct 2013)
What this means for you
This application is over — abandoned 07 Oct 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85692717
- Mark type
- Stylized text
- Filed
- 01 Aug 2012
- Published for opposition
- 08 Jan 2013
- Abandoned
- 07 Oct 2013
- Attorney of record
- Katrina Edge
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Owner
- Agouron Pharmaceuticals, Inc., San Diego, CA, US
- Agouron Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 07 Oct 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 07 Oct 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Mar 2013 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jan 2013 — PUBLISHED FOR OPPOSITION
- 19 Dec 2012 — NOTICE OF PUBLICATION
- 29 Nov 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Nov 2012 — ASSIGNED TO EXAMINER
- 09 Aug 2012 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Aug 2012 — NEW APPLICATION ENTERED